Multicenter Study To Determine Disk Diffusion and Broth Microdilution Criteria for Prediction of High- and Low-Level Mupirocin Resistance in Staphylococcus aureus
- 1 July 2010
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 48 (7), 2469-2475
- https://doi.org/10.1128/jcm.00340-10
Abstract
Mupirocin susceptibility testing of Staphylococcus aureus has become more important as mupirocin is used more widely to suppress or eliminate S. aureus colonization and prevent subsequent health care- and community-associated infections. The present multicenter study evaluated two susceptibility testing screening methods to detect mupirocin high-level resistance (HLR), broth microdilution (BMD) MICs of ≥512 μg/ml, and a 6-mm zone diameter for a disk diffusion (DD) test with a 200-μg disk. Initial testing indicated that with Clinical and Laboratory Standards Institute methods for BMD and DD testing, the optimal conditions for the detection of mupirocin HLR were 24 h of incubation and reading of the DD zone diameters with transmitted light. Using the presence or absence of mupA as the “gold standard” for HLR, the sensitivity and specificity of a single-well 256 μg/ml BMD test were 97 and 99%, respectively, and those for the 200-μg disk test were 98 and 99%, respectively. Testing with two disks, 200 μg and 5 μg, was evaluated for its ability to distinguish HLR isolates (MICs ≥ 512 μg/ml), low-level-resistant (LLR) isolates (MICs = 8 to 256 μg/ml), and susceptible isolates (MICs ≤ 4 μg/ml). Using no zone with both disks as an indication of HLR and no zone with the 5-μg disk plus any zone with the 200-μg disk as LLR, only 3 of the 340 isolates were misclassified, with 3 susceptible isolates being classified as LLR. Use of standardized MIC or disk tests could enable the detection of emerging high- and low-level mupirocin resistance in S. aureus .Keywords
This publication has 17 references indexed in Scilit:
- Mupirocin ResistanceClinical Infectious Diseases, 2009
- Management of multidrug-resistant organisms in health care settings, 2006American Journal of Infection Control, 2007
- Mupirocin-Resistant, Methicillin-Resistant Staphylococcus aureus Strains in Canadian HospitalsAntimicrobial Agents and Chemotherapy, 2007
- Interpretive criteria to differentiate low- and high-level mupirocin resistance in Staphylococcus aureusJournal of Medical Microbiology, 2007
- Randomized Controlled Trial of Chlorhexidine Gluconate for Washing, Intranasal Mupirocin, and Rifampin and Doxycycline Versus No Treatment for the Eradication of Methicillin-Resistant Staphylococcus aureus ColonizationClinical Infectious Diseases, 2007
- Mupirocin-Resistant, Methicillin-ResistantStaphylococcus aureus: Does Mupirocin Remain Effective?Infection Control & Hospital Epidemiology, 2003
- Improvement of mupirocin E-test for susceptibility testing of Staphylococcus aureusJournal of Medical Microbiology, 2003
- Mutations Affecting the Rossman Fold of Isoleucyl-tRNA Synthetase Are Correlated with Low-Level Mupirocin Resistance in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2002
- Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA)Journal of Hospital Infection, 1997
- The antimicrobial activity of mupirocin—an update on resistanceJournal of Hospital Infection, 1991